Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: Individual risks and social determinants

International Journal of Epidemiology

Volumn 40, Issue 2, 2011, Pages 417-428

  Goldhaber Fiebert, Jeremy D ^a   Jeon, Christie Y ^b   Cohen, Ted ^c,d   Murray, Megan B ^c,d,e  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Columbia University ^*  (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Developing countries; Disease interaction; Mycobacterium tuberculosis; Observational study; Social determinants; Type 2 diabetes mellitus

Indexed keywords

BODY MASS; DEVELOPING WORLD; DIABETES; DISEASE INCIDENCE; DISEASE PREVALENCE; HEALTH INSURANCE; HEALTH POLICY; HEALTH SURVEY; OBSERVATIONAL METHOD; RISK ASSESSMENT; RISK FACTOR; SOCIAL IMPACT; TUBERCULOSIS;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CROWDING; DIABETES MELLITUS; EDUCATION; FEMALE; HEALTH CARE POLICY; HEALTH INSURANCE; HEALTH SURVEY; HOUSING; HUMAN; INCIDENCE; INCOME; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SOCIAL ASPECT; TUBERCULOSIS;

ADULT; DEVELOPING COUNTRIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCOME; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SOCIOECONOMIC FACTORS; TUBERCULOSIS;

INDIA; PERU; RUSSIAN FEDERATION;

MYCOBACTERIUM TUBERCULOSIS;

EID: 79953712613     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyq238     Document Type: Article

References (43)

1. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008;5:e152.
2. Stevenson CR, Critchley JA, Forouhi NG et al. Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn 2007;3:228-45.
3. Dye C, Lonnroth K, Jaramillo E, Williams BG, Raviglione M. Trends in tuberculosis incidence and their determinants in 134 countries. Bull World Health Organ 2009;87:683-91.
4. Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009;68: 2240-46.
5. Omran AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q 1971;49:509-38.
6. World Health Organization. The World health report: 1999: Making a difference. Geneva: World Health Organization, 1999.
7. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
8. Raviglione M. XDR-TB: entering the post-antibiotic era? Int J Tuberc Lung Dis 2006;10:1185-87.
9. Corbett EL, Watt CJ, Walker N et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003;163:1009-21.
10. Wells CD, Cegielski JP, Nelson LJ et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 2007;196(Suppl. 1):S86-107.
11. Stevenson CR, Forouhi NG, Roglic G et al. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health 2007;7:234.
12. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007;370:851-58.
13. World Health Organization: World Health Survey. http://www. who.int/healthinfo/survey/en/index.html (12 August 2009, date last accessed).
14. Cohen R, Muzaffar S, Capellan J, Azar H, Chinikamwala M. The validity of classic symptoms and chest radiographic configuration in predicting pulmonary tuberculosis. Chest 1996;109:420-23.
15. Rosen MJ. Chronic cough due to tuberculosis and other infections: ACCP evidence-based clinical practice guidelines. Chest 2006;129(Suppl. 1):197S-201S.
16. Ayles H, Schaap A, Nota A et al. Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIV. PLoS One 2009;4:e5602.
17. Robinson JR, Young TK, Roos LL, Gelskey DE. Estimating the burden of disease. Comparing administrative data and self-reports. Med Care 1997;35:932-47.
18. Wu SC, Li CY, Ke DS. The agreement between self-reporting and clinical diagnosis for selected medical conditions among the elderly in Taiwan. Public Health 2000;114: 137-42.
19. Goldman N, Lin IF, Weinstein M, Lin YH. Evaluating the quality of self-reports of hypertension and diabetes. J Clin Epidemiol 2003;56:148-54.
20. Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004;57:1096-103.
21. El Fakiri F, Bruijnzeels MA, Hoes AW. No evidence for marked ethnic differences in accuracy of self-reported diabetes, hypertension, and hypercholesterolemia. J Clin Epidemiol 2007;60:1271-79.
22. Molenaar EA, Van Ameijden EJ, Grobbee DE, Numans ME. Comparison of routine care self-reported and biometrical data on hypertension and diabetes: results of the Utrecht Health Project. Eur J Public Health 2007;17:199-205.
23. Kishore B, Nagrath SP, Mathur KS, Hazra DK, Agarwal BD. Manifest, chemical and latent chemical diabetes in pulmonary tuberculosis. J Assoc Physicians India 1973;21:875-81.
24. Oluboyo PO, Erasmus RT. The significance of glucose intolerance in pulmonary tuberculosis. Tubercle 1990;71: 135-38.
25. Goyal BN, Dubey AL, Joshi LD, Saxena HN. Study of diabetic status in pulmonary tuberculosis. J Diab Assoc India 1978;18:191-97.
26. Singh MM, Biswas SK. AS. Impaired glucose tolerance in active pulmonary tuberculosis. Indian J Tuberculosis 1984; 31:118-21.
27. World Bank. World Development Indicators. http://www. worldbank.org/data (12 August 2009, date last accessed).
28. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-31.
29. International Diabetes Federation. Diabetes Atlas. http://www.eatlas.idf.org/ (26 October 2008, date last accessed).
30. World Health Organization. The stop TB strategy, case reports, treatment outcomes and estimates of TB burden. http://www.who.int/tb/publications/global_report/2007/annex_2_ download/en/index.html (12 August 2009, date last accessed).
31. Heston A, Summers R, Aten B. University of Pennsylvania Center for International Comparisons of Production, Income and Prices: Penn World Table Version 6.2 2006. http://pwt.econ.upenn.edu (12 August 2009, date last accessed).
32. Spiegelman D, Zhao B, Kim J. Correlated errors in biased surrogates: study designs and methods for measurement error correction. Stat Med 2005;24:1657-82.
33. Danaei G, Friedman AB, Oza S, Murray CJ, Ezzati M. Diabetes prevalence and diagnosis in US states: analysis of health surveys. Popul Health Metr 2009;7:16.
34. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med 1999;341:1906-12.
35. Muller LM, Gorter KJ, Hak E et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005;41:281-8.
36. Brar I, Shuter J, Thomas A, Daniels E, Absalon J. A comparison of factors associated with prevalent diabetes mellitus among HIV-Infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort. J Acquir Immune Defic Syndr 2007;45:66-71.
37. Butt AA, McGinnis K, Rodriguez-Barradas MC et al. HIV infection and the risk of diabetes mellitus. AIDS 2009;23: 1227-34.
38. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999;353:2093-99.
39. Chronister CL, Gurwood AS. Type 2 diabetes in association with HIV-1 protease inhibitors in HIV-infected patients. J Am Optom Assoc 1998;69:695-98.
40. Tien PC, Schneider MF, Cole SR et al. Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study. AIDS 2007;21:1739-45.
41. Urso R, Croce GF, Tubili C et al. [Dysmetabolic syndrome related to HIV-1 protease inhibitors. Review of the literature and personal data]. Recenti Prog Med 2000;91:78-85.
42. Visnegarwala F, Chen L, Raghavan S, Tedaldi E. Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection. J Infect 2005;50:331-37.
43. Harries AD, Billo N, Kapur A. Links between diabetes mellitus and tuberculosis: should we integrate screening and care? Trans R Soc Trop Med Hyg 2009;103: 1-2.